In September, the first 10 products were identified for negotiation with Centers for Medicare and ...
Read More
Over the course of our 25 years in the business, we've realized that when a life sciences company ...
Sometimes pharma companies and their partners need to expand “the whole menu, not just the pie” in ...
Experienced leaders who’ve worked across both academia and industry shared their lessons learned ...
Market access negotiations are complex. Depending on the product and competitive context, payers ...
Value-based or pay-for-performance approaches to reimbursement for drugs and devices represent a ...
Originally posted on September 25, 2019 on the Association of Strategic Alliances (ASAP) blog.
As traditional sources of funding dip, universities are scrambling for the cash to support ...
by John Larson and Troy Windt
Strategic partnerships have long been a major feature of the pharmaceutical industry. In-licensing, ...
by Sara Keen and Britt Aylor
The outsourcing of clinical research is a significant part of the product development landscape in ...
.png?width=512&height=130&name=vantage-logo(2).png "Vantage Partners")
